Cadila Healthcare gets Warning Letter from USFDA

For its Moraiya formulation facility and Ahmedabad API facility (Zyfine)

Cadila Healthcare has received a Warning Letter issued by the US FDA relating to its Moraiya formulation facility and Ahmedabad API facility (Zyfine).

Powered by Capital Market - Live News